COMPOSITION

Each vaccine contains: inactivated culture of Clostridium chauvoei not less than 30 OU, inactivated culture of Clostridium novyi B not less than 7.5 OU, inactivated culture of Clostridium novyi D not less than 7.5 OU, toxoid of Clostridium novyi B to induce a serological response not less than 3.5 IU per ml of serum, toxoid of Clostridium novyi D to induce a serological response not less than 10 IU per ml of serum, ß toxoid of Clostridium perfringens to induce a serological response not less than 10 IU per ml of serum, toxoid of Clostridium perfringens to induce a serological response not less than 5 IU per ml of serum, toxoid Clostridium septicum to induce a serological response not less than 2.5 IU per ml of serum, toxoid of Clostridium tetani to induce a serological response not less than 2.5 IU per ml of serum.

PHARMACEUTICAL FORM

Injectable suspension.

TARGET SPECIES

Cattle and sheep.

INDICATIONS

Prevention of diseases caused by Clostridium perfringens B, C and D, Clostridium novyi B and D, Clostridium chauvoei, Clostridium septicum and Clostridium tetani in cattle and sheep, including: enterotoxaemia, lamb dysentery, necrotic enteritis, pulpy kidney disease, infectious necrotic hepatitis, bacillary haemoglobinuria, red water disease, malignant edema, blackleg and tetanus.

DOSAGE